HCmed Innovations Statistics
Total Valuation
TPE:6934 has a market cap or net worth of TWD 2.55 billion. The enterprise value is 2.29 billion.
Important Dates
The next estimated earnings date is Friday, March 12, 2027.
| Earnings Date | Mar 12, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
TPE:6934 has 36.13 million shares outstanding. The number of shares has increased by 11.15% in one year.
| Current Share Class | 36.13M |
| Shares Outstanding | 36.13M |
| Shares Change (YoY) | +11.15% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 25.65% |
| Owned by Institutions (%) | 15.81% |
| Float | 19.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.57 |
| PB Ratio | 5.15 |
| P/TBV Ratio | 5.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.06, with a Debt / Equity ratio of 0.20.
| Current Ratio | 8.06 |
| Quick Ratio | 7.32 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -52.78 |
Financial Efficiency
Return on equity (ROE) is -32.53% and return on invested capital (ROIC) is -17.47%.
| Return on Equity (ROE) | -32.53% |
| Return on Assets (ROA) | -25.06% |
| Return on Invested Capital (ROIC) | -17.47% |
| Return on Capital Employed (ROCE) | -22.31% |
| Weighted Average Cost of Capital (WACC) | 10.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.28 |
| Inventory Turnover | 5.41 |
Taxes
| Income Tax | -12,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.17% in the last 52 weeks. The beta is 1.23, so TPE:6934's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | +2.17% |
| 50-Day Moving Average | 77.25 |
| 200-Day Moving Average | 83.35 |
| Relative Strength Index (RSI) | 38.50 |
| Average Volume (20 Days) | 71,099 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:6934 had revenue of TWD 137.15 million and -123.89 million in losses. Loss per share was -3.55.
| Revenue | 137.15M |
| Gross Profit | 17.42M |
| Operating Income | -129.32M |
| Pretax Income | -123.90M |
| Net Income | -123.89M |
| EBITDA | -108.76M |
| EBIT | -129.32M |
| Loss Per Share | -3.55 |
Full Income Statement Balance Sheet
The company has 362.12 million in cash and 99.98 million in debt, with a net cash position of 262.14 million or 7.26 per share.
| Cash & Cash Equivalents | 362.12M |
| Total Debt | 99.98M |
| Net Cash | 262.14M |
| Net Cash Per Share | 7.26 |
| Equity (Book Value) | 494.90M |
| Book Value Per Share | 13.70 |
| Working Capital | 384.30M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -120.99 million and capital expenditures -65.70 million, giving a free cash flow of -186.68 million.
| Operating Cash Flow | -120.99M |
| Capital Expenditures | -65.70M |
| Depreciation & Amortization | 20.56M |
| Net Borrowing | -17.06M |
| Free Cash Flow | -186.68M |
| FCF Per Share | -5.17 |
Full Cash Flow Statement Margins
Gross margin is 12.70%, with operating and profit margins of -94.30% and -90.33%.
| Gross Margin | 12.70% |
| Operating Margin | -94.30% |
| Pretax Margin | -90.34% |
| Profit Margin | -90.33% |
| EBITDA Margin | -79.30% |
| EBIT Margin | -94.30% |
| FCF Margin | n/a |
Dividends & Yields
TPE:6934 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -11.15% |
| Shareholder Yield | -11.15% |
| Earnings Yield | -5.03% |
| FCF Yield | -7.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |